Zafgen Inc

Permanently closed
Call
Website

Advertisement

35 Landsdowne St
Cambridge, MA 02139

Larimar Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, dedicated to developing treatments for complex rare diseases. Their lead product candidate, nomlabofusp, is currently undergoing a Phase 2 clinical trial as a potential treatment for Friedreich's ataxia, a rare and progressive genetic disorder.

Utilizing a proprietary intracellular delivery platform, Larimar Therapeutics aims to deliver proteins and other molecules inside cells, potentially addressing deficiencies in intracellular proteins across various rare diseases. The company is committed to improving the lives of patients with rare diseases, empowering them to pursue their dreams.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.

Advertisement